{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:32:37Z","timestamp":1684470757743},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:00:00Z","timestamp":1293062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/hr.2010.260","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T07:02:01Z","timestamp":1293087721000},"page":"509-515","source":"Crossref","is-referenced-by-count":14,"title":["Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension"],"prefix":"10.1038","volume":"34","author":[{"given":"Roberto","family":"Fogari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibilla A T","family":"Salvadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amedeo","family":"Mugellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"key":"BFhr2010260_CR1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","volume":"32","author":"NJ Brown","year":"1998","unstructured":"Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE . Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32: 965\u2013971.","journal-title":"Hypertension"},{"issue":"Suppl","key":"BFhr2010260_CR2","doi-asserted-by":"publisher","first-page":"18C","DOI":"10.1016\/S0002-9149(01)01509-0","volume":"87","author":"DE Vaughan","year":"2001","unstructured":"Vaughan DE . Angiotensin, fibrinolysis and vascular homeostasis. Am J Cardiol 2001; 87 (Suppl): 18C\u201324C.","journal-title":"Am J Cardiol"},{"key":"BFhr2010260_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","volume":"98","author":"CM Ferrario","year":"2006","unstructured":"Ferrario CM, Strawn WB . Role of the renin-angiotensin-aldosterone system and pro-inflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121\u2013128.","journal-title":"Am J Cardiol"},{"key":"BFhr2010260_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1172\/JCI117786","volume":"95","author":"EP Feener","year":"1995","unstructured":"Feener EP, Nortrup JM, Aiello LP, King GL . Angiotensin II induces plasminogen activator inhibitor 1 and 2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995; 95: 1353\u20131362.","journal-title":"J Clin Invest"},{"key":"BFhr2010260_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1055\/s-0038-1656136","volume":"77","author":"H Nishimura","year":"1997","unstructured":"Nishimura H, Tsuji H, Masuda H, Nakagawa K, Nakahara Y, Kitamura H, Kasahara T, Sugano T, Yoshizumi M, Sawada S, Nakagawa M . Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 1997; 77: 1189\u20131195.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR6","first-page":"1928","volume":"88","author":"JA Olson","year":"1991","unstructured":"Olson JA, Shiverick KT, Ogilvie S, Buhi WC, Raizada MK . Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes. Neurobiology 1991; 88: 1928\u20131932.","journal-title":"Neurobiology"},{"key":"BFhr2010260_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.CIR.90.1.362","volume":"90","author":"RT Van Leeuwen","year":"1994","unstructured":"Van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G . Angiotensin II increases plasminogen activator inhibitor type 1 and tissue type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994; 90: 362\u2013368.","journal-title":"Circulation"},{"key":"BFhr2010260_CR8","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/01.CIR.87.6.1969","volume":"87","author":"PM Ridker","year":"1993","unstructured":"Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE . Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin-system and fibrinolytic function. Circulation 1993; 87: 1969\u20131973.","journal-title":"Circulation"},{"key":"BFhr2010260_CR9","first-page":"336","volume":"85","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE . Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor 1 production. J Clin Endocrinol Metab 2000; 85: 336\u2013344.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr2010260_CR10","first-page":"285","volume":"38","author":"JJ Emeis","year":"1992","unstructured":"Emeis JJ, Tranquille N . On the role of bradykinin in secretion from vascular endothelial cells. Agents Actions 1992; 38: 285\u2013292.","journal-title":"Agents Actions"},{"key":"BFhr2010260_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/01.HYP.33.6.1431","volume":"33","author":"NJ Brown","year":"1999","unstructured":"Brown NJ, Gainer JV, Stein CM, Vaughan DE . Bradykinin stimulate tissue plasminogen activator release in human vasculature. Hypertension 1999; 33: 1431\u20131435.","journal-title":"Hypertension"},{"key":"BFhr2010260_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0735-1097(94)90543-6","volume":"24","author":"RA Wright","year":"1994","unstructured":"Wright RA, Flapan AD, Alberti KG, Ludlam CA, Fox KA . Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol 1994; 24: 67\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010260_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/01.CIR.96.2.442","volume":"96","author":"DE Vaughan","year":"1997","unstructured":"Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA . Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction: HEART Study investigators. Circulation 1997; 96: 442\u2013447.","journal-title":"Circulation"},{"key":"BFhr2010260_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/clc.4960200507","volume":"20","author":"H Soejima","year":"1997","unstructured":"Soejima H, Ogawa H, Yasue H, Suefuji H, Kaikita K, Nishiyama K . Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction. Clin Cardiol 1997; 20: 441\u2013445.","journal-title":"Clin Cardiol"},{"key":"BFhr2010260_CR15","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0735-1097(98)00481-1","volume":"32","author":"JW Sayer","year":"1998","unstructured":"Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P, Timmis AD . Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin converting enzyme inhibitors. J Am Coll Cardiol 1998; 32: 1962\u20131968.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010260_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0002-8703(99)70368-6","volume":"137","author":"K Sakata","year":"1999","unstructured":"Sakata K, Shirotani M, Yoshida H, Urano T, Takada Y, Takada A . Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension. Am Heart J 1999; 137: 1094\u20131099.","journal-title":"Am Heart J"},{"key":"BFhr2010260_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00228-003-0621-3","volume":"59","author":"R Fogari","year":"2003","unstructured":"Fogari R, Preti P, Lazzari P, Corradi L, Zoppi A, Fogari E, Mugellini A . Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients. Eur J Clin Pharmacol 2003; 59: 271\u2013275.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl K","key":"BFhr2010260_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/eurheartj\/16.suppl_K.31","volume":"16","author":"DE Vaughan","year":"1995","unstructured":"Vaughan DE, Rouleau JI, Pfeffer MA . Role of the fibrinolytic system in preventing myocardial infarction. Eur Heart J 1995; 16 (Suppl K): 31\u201336.","journal-title":"Eur Heart J"},{"key":"BFhr2010260_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0735-1097(03)00162-1","volume":"41","author":"T Matsumoto","year":"2003","unstructured":"Matsumoto T, Minai K, Horie H, Ohira N, Takashima H, Tarutani Y, Yasuda Y, Ozawa T, Matsuo S, Kinoshita M, Horie M . Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients. J Am Coll Cardiol 2003; 41: 1373\u20131379.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010260_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/BF00315549","volume":"44","author":"JH Janson","year":"1993","unstructured":"Janson JH, Borman K, Nilsson TK . Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction. Eur J Clin Pharmacol 1993; 44: 485\u2013488.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFhr2010260_CR21","first-page":"31","volume":"4","author":"K Lottermoser","year":"1999","unstructured":"Lottermoser K, Wostmann B, Weisser B, Hertfelder HJ, Schmitz U, Vetter H, Dusing R . Effects of captopril on fibrinolytic function in healthy humans. Eur J Med Res 1999; 4: 31\u201334.","journal-title":"Eur J Med Res"},{"key":"BFhr2010260_CR22","first-page":"35","volume":"27","author":"A Trifiletti","year":"1997","unstructured":"Trifiletti A, Barbera N, Scamardi R, Bagnato L, Pizzoleo MA, Nevoso A, Lasco A, Pedull\u00e0 M, Frisina N . Effects of medium-term antihypertensive therapy on hemostatic parameters in patients with essential hypertension. Haemostasis 1997; 27: 35\u201338.","journal-title":"Haemostasis"},{"key":"BFhr2010260_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0049-3848(91)90148-P","volume":"62","author":"MC Alessi","year":"1991","unstructured":"Alessi MC, Juhan-Vague I, Declerck PJ, Collen D . Molecular forms of plasminogen activator inhibitor 1 (PAI-1) and tissue type plasminogen activator (t-PA) in human plasma. Thromb Res 1991; 62: 275\u2013285.","journal-title":"Thromb Res"},{"key":"BFhr2010260_CR24","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1111\/j.1538-7836.2004.00948.x","volume":"2","author":"T Hrafnkelsdottir","year":"2004","unstructured":"Hrafnkelsdottir T, Gudnason T, Wall U, Jern C, Jern S . Regulation of local availability of active tissue-type plasminogen activator in vivo in man. J Thromb Haemost 2004; 2: 1960\u20131968.","journal-title":"J Thromb Haemost"},{"key":"BFhr2010260_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.108.111559","volume":"52","author":"C Giannarelli","year":"2008","unstructured":"Giannarelli C, Virdis A, De Negri F, Duranti E, Magagna A, Ghiadoni L, Salvetti A, Taddei S . Tissue-type plasminogen activator release in healthy subjects and hypertensive patients. Relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension 2008; 52: 314\u2013321.","journal-title":"Hypertension"},{"key":"BFhr2010260_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0895-7061(99)00286-1","volume":"13","author":"K Lottermoser","year":"2000","unstructured":"Lottermoser K, Hertfelder HH, Vetter H, Dusing R . Fibrinolytic function in diuretic-induced volume depletion. Am J Hypertens 2000; 13: 359\u2013363.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0895-7061(99)00145-4","volume":"11","author":"Y Erdem","year":"1999","unstructured":"Erdem Y, Usalan C, Haznedaro\u2202lu IC, Altun B, Arici M, Yasavul U, Turgan C, Ca\u01e7lar S . Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension. Am J Hypertens 1999; 11: 1071\u20131076.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FJC.0b013e31805751d3","volume":"50","author":"L Liu","year":"2007","unstructured":"Liu L, Zhao SP, Zhou HN, Li QZ, Li Jx . Effect of fluvastatin and valsartan, alone and in combination, on post-prandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. J Cardiovasc Pharmacol 2007; 50: 50\u201355.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2010260_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/01.HYP.27.6.1299","volume":"27","author":"I Seljeflot","year":"1996","unstructured":"Seljeflot I, Moan A, Kjeldsen S, Sandvik E, Arnesen H . Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension. Hypertension 1996; 27: 1299\u20131304.","journal-title":"Hypertension"},{"key":"BFhr2010260_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0011-393X(01)80043-6","volume":"62","author":"R Fogari","year":"2001","unstructured":"Fogari R, Zoppi A, Malamani G, Marasi G, Pesce RM, Banderali A, Mugellini A . Effects of four angiotensin II-receptor antagonists on fibrinolysis in post-menopausal women with hypertension. Curr Ther Res 2001; 62: 68\u201378.","journal-title":"Curr Ther Res"},{"key":"BFhr2010260_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1463-1326.2004.00316.x","volume":"6","author":"T Skurk","year":"2004","unstructured":"Skurk T, Lee YM, Nicuta-Rolfs TO, Haastert B, Wirth A, Hauner H . Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension. Diabetes Obes Metab 2004; 6: 56\u201362.","journal-title":"Diabetes Obes Metab"},{"key":"BFhr2010260_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1607-551X(09)70304-3","volume":"22","author":"TH Lin","year":"2006","unstructured":"Lin TH, Voon WC, Yen HW, Huang CH, Su HM, Lai WT, Sheu SH . Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters. Kaohsiung J Med Sci 2006; 22: 177\u2013183.","journal-title":"Kaohsiung J Med Sci"},{"key":"BFhr2010260_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/01.HYP.34.2.285","volume":"34","author":"NJ Brown","year":"1999","unstructured":"Brown NJ, Agirbasli M, Vaughan DE . Comparative effect of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 1999; 34: 285\u2013290.","journal-title":"Hypertension"},{"key":"BFhr2010260_CR34","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1161\/01.CIR.99.23.2983","volume":"99","author":"NE Goodfield","year":"1999","unstructured":"Goodfield NE, Newby DE, Ludlam CA, Flapan AD . Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation 1999; 99: 2983\u20132985.","journal-title":"Circulation"},{"key":"BFhr2010260_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0895-7061(01)02140-9","volume":"14","author":"R Fogari","year":"2001","unstructured":"Fogari R, Zoppi A, Preti P, Fogari E, Malamani G, Mugellini A . Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive post-menopausal women. Am J Hypertens 2001; 14: 921\u2013926.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0895-7061(01)02340-8","volume":"15","author":"R Fogari","year":"2002","unstructured":"Fogari R, Mugellini A, Zoppi A, Corradi L, Preti P, Lazzari P, Derosa G . Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetics. Am J Hypertens 2002; 15: 316\u2013320.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2165\/00044011-200323110-00004","volume":"23","author":"S Paterna","year":"2003","unstructured":"Paterna S, Di Garbo V, Avellone G, Di Pasquale P, Cacia A, Tuttolomondo A, Follone G, Cardinale A, Maniscalchi T, Licata G . Effects of losartan and delapril on the fibrinolytic system in patients with mild to moderate hypertension. Clin Drug Invest 2003; 23: 717\u2013724.","journal-title":"Clin Drug Invest"},{"key":"BFhr2010260_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1524-6175.2007.06506.x","volume":"9","author":"MM Hirschl","year":"2007","unstructured":"Hirschl MM, Bur A, Woisetschlaeger C, Derhaschnig U, Laggner AN . Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients. J Clin Hypertens 2007; 9: 430\u2013435.","journal-title":"J Clin Hypertens"},{"key":"BFhr2010260_CR39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0038-1657246","volume":"48","author":"EJP Brummer","year":"1982","unstructured":"Brummer EJP, Baret-Bergshoeff MM, Allen RA, Schicht I, Bertina RM, Schalekamp MADH . The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity. Analysis of responders and non responders. Thromb Haemost 1982; 48: 156.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V91.2.529","volume":"91","author":"U Wall","year":"1998","unstructured":"Wall U, Jern S, Tengborn L, Jern C . Evidence of local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 1998; 91: 529\u2013537.","journal-title":"Blood"},{"key":"BFhr2010260_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1055\/s-0038-1646997","volume":"60","author":"MC Alessi","year":"1988","unstructured":"Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D . Insulin stimulates the synthesis of plasminogen activator inhibitor by the human hepatocellular cell line HepG2. Thromb Haemost 1988; 60: 491\u2013494.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR42","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1161\/01.ATV.13.12.1822","volume":"13","author":"TK Nordt","year":"1993","unstructured":"Nordt TK, Klassen KJ, Schneider DJ, Sobel BE . Augmentation of synthesis of plasminogen activator inhibitor type 1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 1993; 13: 1822\u20131828.","journal-title":"Arterioscler Thromb"},{"key":"BFhr2010260_CR43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.CIR.91.3.764","volume":"91","author":"TK Nordt","year":"1995","unstructured":"Nordt TK, Sawa H, Fujii S, Sobel BE . Induction of plasminogen activator inhibitor type -1(PAI-1) by proinsulin and insulin in vivo. Circulation 1995; 91: 764\u2013770.","journal-title":"Circulation"},{"key":"BFhr2010260_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF00403280","volume":"34","author":"I Juan-Vague","year":"1991","unstructured":"Juan-Vague I, Alessi MC, Vague P . Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457\u2013462.","journal-title":"Diabetologia"},{"key":"BFhr2010260_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/0895-7061(95)00442-4","volume":"9","author":"JR Jeng","year":"1996","unstructured":"Jeng JR, Sheu WHH, Jeng SC, Huang SH, Shieh SM . Impaired fibrinolysis and insulin resistance in patients with hypertension. Am J Hypertens 1996; 9: 484\u2013490.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0038-1646598","volume":"61","author":"I Juhan Vague","year":"1989","unstructured":"Juhan Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P . Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients: Relationship with plasma insulin. Thromb Haemost 1989; 61: 370\u2013373.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR47","first-page":"214","volume":"237","author":"RA De Fronzo","year":"1979","unstructured":"De Fronzo RA, Tobin JA, Andres B . Glucose clamp technique, a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: 214\u2013223.","journal-title":"Am J Physiol"},{"key":"BFhr2010260_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/08037059209077502","volume":"1","author":"L Hansson","year":"1992","unstructured":"Hansson L, Hedner T, Dahlof B . Prospective, randomized, open, blinded end-point (PROBE) study: a novel design for intervention trials. Blood Press 1992; 1: 113\u2013114.","journal-title":"Blood Press"},{"key":"BFhr2010260_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0038-1661109","volume":"51","author":"JH Verheijen","year":"1984","unstructured":"Verheijen JH, Chang GTC, Kluff C . Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activator in plasma. Thromb Haemost 1984; 51: 392\u2013395.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/01.HYP.0000040264.15961.48","volume":"40","author":"NJ Brown","year":"2002","unstructured":"Brown NJ, Kumar S, Painter CA, Vaughan DE . ACE inhibition versus angiotensin type 1 receptor antagonism. Differential effects on PAI-1 over time. Hypertension 2002; 40: 859\u2013865.","journal-title":"Hypertension"},{"key":"BFhr2010260_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/01.ATV.13.2.162","volume":"13","author":"AR Folsom","year":"1993","unstructured":"Folsom AR, Quamhieh DT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK . Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII and other hemostatic factors in moderately overweight adults. Arterioscler Thromb Vasc Biol 1993; 13: 162\u2013169.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr2010260_CR52","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1172\/JCI118312","volume":"96","author":"DM Kerins","year":"1995","unstructured":"Kerins DM, Hao Q, Vaughan DE . Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995; 96: 2515\u20132520.","journal-title":"J Clin Invest"},{"key":"BFhr2010260_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0167-0115(99)00047-6","volume":"83","author":"I Moeller","year":"1999","unstructured":"Moeller I, Clune EF, Fennessy PA, Bingley JA, Albiston AL, Mendelsohn FA, Chai SY . Up-regulation of AT4 receptor levels in carotid arteries following balloon injury. Regul Pept 1999; 83: 25\u201330.","journal-title":"Regul Pept"},{"key":"BFhr2010260_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-0038-1651126","volume":"57","author":"P Vague","year":"1987","unstructured":"Vague P, Juhan Vague I, Aless MC, Badier C, Valadier J . Metformin decreases the high plasminogen activator inhibitor capacity, plasma insulin and triglycerides levels in non-diabetic obese subjects. Thromb Haemost 1987; 57: 326\u2013328.","journal-title":"Thromb Haemost"},{"key":"BFhr2010260_CR55","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00005344-199810000-00014","volume":"32","author":"R Fogari","year":"1998","unstructured":"Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, Lusardi P . ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 1998; 32: 616\u2013620.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2010260_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/00004872-199609000-00008","volume":"14","author":"A Moan","year":"1996","unstructured":"Moan A, Hoieggen A, Seljieflot I, Risanger T, Aenesen H, Kjeldsen SE . The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens 1996; 14: 1093\u20131097.","journal-title":"J Hypertens"},{"key":"BFhr2010260_CR57","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.HYP.28.3.392","volume":"28","author":"M Laakso","year":"1996","unstructured":"Laakso M, Karjalainen L, Lempiainen-Kuosa P . Effects of losartan on insulin sensitivity in hypertensive subjects. Hypertension 1996; 28: 392\u2013396.","journal-title":"Hypertension"},{"issue":"Suppl 5","key":"BFhr2010260_CR58","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1097\/00005344-199000005-00007","volume":"15","author":"H Lithell","year":"1990","unstructured":"Lithell H, Pollare T, Berne C . Insulin sensitivity in newly detected hypertensive patients:influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharmacol 1990; 15 (Suppl 5): S46\u2013S52.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 2","key":"BFhr2010260_CR59","first-page":"287","volume":"3","author":"E Torlone","year":"1991","unstructured":"Torlone E, Bolli GB . Angiotensin converting enzyme inhibition improves insulin sensitivity in type II diabetes mellitus. Arch Gerontol Geriatr 1991; 3 (Suppl 2): 287\u2013290.","journal-title":"Arch Gerontol Geriatr"},{"key":"BFhr2010260_CR60","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/0895-7061(95)00018-K","volume":"8","author":"B Falkner","year":"1995","unstructured":"Falkner B, Canessa M, Anzalone D . Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension. Am J Hypertens 1995; 8: 454\u2013460.","journal-title":"Am J Hypertens"},{"key":"BFhr2010260_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/HJH.0b013e3280bad9b4","volume":"25","author":"Blood Pressure Lowering Treatment Trialist's Collaboration","year":"2007","unstructured":"Blood Pressure Lowering Treatment Trialist's Collaboration. Pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25: 951\u2013958.","journal-title":"J Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010260","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:51Z","timestamp":1684429611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["BFhr2010260"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.260","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,23]]}}}